Intermediate filaments in malignant melanomas. Identification and use as marker in surgical pathology

Area of Science:

• Cell Biology
• Biochemistry
• Oncology

Background:

• Intermediate-sized filaments are crucial cytoskeletal components.
• Melanocytes, pigment-producing cells, have a debated origin (mesenchymal vs. neuroectodermal).
• Melanomas are malignant tumors arising from melanocytes.

Purpose of the Study:

• To investigate the types of intermediate filaments present in human melanomas and normal melanocytes.
• To determine if melanocytes and melanomas express keratin, vimentin, desmin, neurofilament protein, or glial filament protein.
• To utilize intermediate filament expression for differential diagnosis of melanomas.

Main Methods:

• Immunofluorescence microscopy was employed.
• Antibodies against keratin, vimentin, desmin, neurofilament protein, and glial filament protein were used.
• Human malignant melanomas, metastases, normal melanocytes (human skin, rat eye), epidermis, muscle, and neural tissues were analyzed.

Main Results:

• Human melanomas and normal melanocytes exclusively contained vimentin-type intermediate filaments.
• No reactivity was observed with antibodies against keratin, desmin, neurofilaments, or glial filaments in melanocytes or melanomas.
• Control tissues showed expected reactivity: epidermis (keratin), muscle (desmin), and neural tissue (neurofilaments, glial filaments).

Conclusions:

• Melanocytes exhibit a mesenchymal character based on their exclusive vimentin intermediate filament expression.
• An early neuroectodermal origin for melanocytes remains a possibility.
• The exclusive presence of vimentin in melanomas can aid in differentiating them from other tumor types.